TBC1D20

Chr 20AR

TBC1 domain family member 20

Also known as: C20orf140, WARBM4

This gene encodes a GTPase-activating protein that accelerates GTP hydrolysis for Rab1, Rab2, and RAB18 small GTPases and is involved in maintaining endoplasmic reticulum structure. Mutations cause Warburg micro syndrome 4, an autosomal recessive disorder characterized by congenital microcephaly, microphthalmia, congenital cataracts, and intellectual disability. The gene is highly constrained against loss-of-function variants (pLI 0.93, LOEUF 0.36), consistent with its role in this severe early-onset developmental syndrome.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.361 OMIM phenotype
Clinical SummaryTBC1D20
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.93). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.36LOEUF
pLI 0.931
Z-score 3.41
OE 0.12 (0.050.36)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.21Z-score
OE missense 0.77 (0.680.88)
176 obs / 227.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.12 (0.050.36)
00.351.4
Missense OE0.77 (0.680.88)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 2 / 17.3Missense obs/exp: 176 / 227.6Syn Z: 0.74

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TBC1D20 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →